D Dubovsky, L Kernoff, P Jacobs. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Acute DiseaseAdolescentAdultAgedCytarabine/therapeutic useDoxorubicin/therapeutic useDrug Therapy, CombinationEtoposide/therapeutic useFemaleHumansLeukemia/complicationsLeukemia/drug therapyLeukemia/mortalityMaleMiddle AgedPodophyllotoxin/analogs & derivativesRemission, SpontaneousSepsis/complicationsTime Factors
Substances： See more » CytarabineEtoposideDoxorubicinPodophyllotoxin
Year: 1978 PMID： 738325 DOI： 10.1016/0014-2964(78)90223-2
Source DB: PubMed Journal: Eur J Cancer ISSN： 0014-2964 Impact factor: 9.162